JOHNSON & JOHNSON (JNJ) Stock Price, Quote, News and Overview
NYSE:JNJ - New York Stock Exchange, Inc. - US4781601046 - Common Stock
JNJ Quote and Key Statistics
JOHNSON & JOHNSON
NYSE:JNJ (1/22/2025, 4:42:26 PM)
After market: 145.15 -0.12 (-0.08%)145.27
-2.88 (-1.94%)
JNJ Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.74% | ||
| ROA | 8.24% | ||
| ROE | 20.93% | ||
| Debt/Equity | 0.47 |
JNJ Performance and Technical Analysis
JNJ Ownership and Analysts
JNJ Latest News and Analysis
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.
These S&P500 stocks are moving in today's session
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index.
Curious about the market action on Wednesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
S&P 500 Hits Fresh Records At 6,100: Strong Earnings, Trump's AI Wager Fuel Bull Run
Market surges on AI Stargate initiative & strong earnings. S&P 500 hits record high of 6,100 points, led by tech giants & semiconductor stocks.
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, despite investor concerns over M&A and deals.
Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript
JNJ earnings call for the period ending December 31, 2024.
Stocks making the biggest midday moves: Netflix, Johnson & Johnson, Oracle, Ford and more
These are some of the the stocks posting the largest moves in midday trading.
About JNJ
Company Profile
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 131,900 full-time employees. The firm's primary focus is products related to human health and well-being. The company operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).
Company Info
JOHNSON & JOHNSON
One Johnson & Johnson Plaza
New Brunswick NEW JERSEY 08933 US
CEO: A. Gorsky
Employees: 131900
Company Website: https://www.jnj.com/
Investor Relations: https://www.investor.jnj.com
Phone: 17325242455
JNJ Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 74.14 | 715.77B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.22 | 357.84B | ||
| MRK | MERCK & CO. INC. | 16.08 | 242.04B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 17.9 | 211.49B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.16 | 196.27B | ||
| PFE | PFIZER INC | 10.08 | 147.40B | ||
| SNY | SANOFI-ADR | 12.38 | 129.15B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.79 | 115.79B | ||
| ZTS | ZOETIS INC | 28.93 | 75.18B | ||
| GSK | GSK PLC-SPON ADR | 8.17 | 68.21B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 21.48 | 40.87B | ||
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 7.92 | 24.94B |